SynopsisThe global market for Gabapentin was valued at US$ 1598 million in the year 2024 and is projected to reach a revised size of US$ 1807 million by 2031, growing at a CAGR of 1.8% during the forecast period. Gabapentin is a medication used to treat epilepsy.....
SynopsisThe global market for Medical Tubing was valued at US$ 8788 million in the year 2024 and is projected to reach a revised size of US$ 15830 million by 2031, growing at a CAGR of 8.9% during the forecast period. Medical tubing is tubing that meets medical .....
SynopsisThe global market for Aesthetic Medicine and Cosmetics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Aesthetic medicine specializes in improvi.....
SynopsisThe global market for Antihypertensive Beta Blockers was valued at US$ 18500 million in the year 2024 and is projected to reach a revised size of US$ 24340 million by 2031, growing at a CAGR of 4.0% during the forecast period. Antihypertensive beta block.....
SynopsisThe global market for Rydapt was valued at US$ 545 million in the year 2024 and is projected to reach a revised size of US$ 2082 million by 2031, growing at a CAGR of 21.4% during the forecast period. Rydapt is a multi-targeted protein kinase inhibitor t.....
SynopsisThe global market for Gene Synthesis Service was valued at US$ 669 million in the year 2024 and is projected to reach a revised size of US$ 1904 million by 2031, growing at a CAGR of 16.4% during the forecast period. Gene synthesis refers to chemically s.....
SynopsisThe global market for 3D Reconstructed Corneal Model was valued at US$ 23.5 million in the year 2024 and is projected to reach a revised size of US$ 65.6 million by 2031, growing at a CAGR of 15.8% during the forecast period. 3D Reconstructed Corneal Mod.....
SynopsisThe global market for Automated External Defibrillators (AEDs) was valued at US$ 943 million in the year 2024 and is projected to reach a revised size of US$ 1401 million by 2031, growing at a CAGR of 5.9% during the forecast period. Automated External D.....
SynopsisThe global market for Orally Disintegrating Tablet Excipient was valued at US$ 17830 million in the year 2024 and is projected to reach a revised size of US$ 22600 million by 2031, growing at a CAGR of 3.5% during the forecast period. An orally disintegr.....
SynopsisThe global market for High-Throughput POCT Molecular Diagnostics Devices was valued at US$ 8700 million in the year 2024 and is projected to reach a revised size of US$ 10340 million by 2031, growing at a CAGR of 2.5% during the forecast period. High-Thr.....
